We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

FUJIREBIO

Fujirebio is a global leader in the field of IVD testing with more than 50 years’ experience in the conception, devel... read more Featured Products: More products

Download Mobile App





Fujirebio Highlights Its Innovative IVD Testing Solutions for Today and Tomorrow at MEDICA 2021

By LabMedica International staff writers
Posted on 15 Nov 2021

Fujirebio Diagnostics AB (Gothenburg, Sweden) highlighted its innovative IVD testing solutions at the 2021 edition of MEDICA, the world's largest trade fair for medical technology, held from 15 to 18 November in Düsseldorf, Germany. More...

Fujirebio’s IVD product lines span from specialized manual testing to fully automated routine clinical laboratory testing solutions and include both novel and routine biomarkers. The company covers a variety of disease states such as infectious, oncology, genetic testing, thyroid, fertility, tissue typing, neurodegeneration and bone metabolism. At MEDICA 2021, Fujirebio presented LUMIPULSE G1200, a robust mid-sized fully automated immunoassay instrument that uses a unique mono test cartridge concept with a true throughput of 120 tests per hour. Also on display was the LUMIPULSE G600II, the latest member of the LUMIPULSE G series, the chemiluminescent enzyme immunoassay (CLEIA) analyzers from Fujirebio. LUMIPULSE G600II is a compact and robust benchtop analyzer featuring a constant throughput of 60 tests per hour. The system uses a unique mono test cartridge concept (the same cartridge concept as the mid-sized LUMIPULSE G1200 analyzer) and offers outstanding flexibility and easy handling to hospitals and clinical laboratories.

Among its kits for fully automated testing, Fujirebio highlighted Lumipulse® G B•R•A•H•M•S PCT, the most sensitive fully automated Procalcitonin (PCT) test. Immunoreaction cartridges for in vitro diagnostic (IVD) use with a two-step sandwich immunoassay method on the LUMIPULSE G system for the quantitative determination of procalcitonin (PCT) in human serum and plasma. The CE marked assay utilizes proven CLEIA (chemiluminescent enzyme immunoassay) technology with results that are available in up to 35 minutes. Fujirebio showcased its portfolio of COVID-19 diagnostic tests, including the Lumipulse G SARS-CoV-2 S-IgG which is an assay system, including a set of immunoassay reagents, for the quantitative measurement of IgG-type antibodies SARS-CoV-2 spike protein (SARS-CoV-2 S-IgG) in specimens based on CLEIA technology by a specific two-step immunoassay method on the LUMIPULSE G System and with results that are available in up to 30 minutes.

In addition, Fujirebio highlighted the Lumipulse G SARS-CoV-2 Ag for in vitro diagnostic (IVD) use with the Lumipulse G system for the detection and quantitative measurement of SARS-CoV-2 nucleocapsid protein antigen in human nasopharyngeal swab or saliva. The CE marked assay utilizes proven CLEIA (chemiluminescent enzyme immunoassay) technology with results that are available in up to 35 minutes.

Related Links:
Fujirebio Europe 


New
Gold Member
Cardiovascular Risk Test
Metabolic Syndrome Array I & II
Collection and Transport System
PurSafe Plus®
New
Gold Member
Automatic Hematology Analyzer
DH-800 Series
New
Silver Member
PCR Plates
Diamond Shell PCR Plates
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: Mizzou researcher Jimi Cook is on a mission to find a ‘crystal ball’ to predict who will benefit most from cartilage transplant surgery (Photo courtesy of University of Missouri)

Urine Test Could Predict Outcome of Cartilage Transplant Surgery

Cartilage transplant surgery provides an alternative to artificial joint replacements by using donor tissue to restore knee function. While many patients benefit, outcomes can vary, leaving uncertainty... Read more

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Pathology

view channel
Image: Erythrocyte Sedimentation Rate Sample Stability (Photo courtesy of ALCOR Scientific)

ESR Testing Breakthrough Extends Blood Sample Stability from 4 to 28 Hours

Erythrocyte sedimentation rate (ESR) is one of the most widely ordered blood tests worldwide, helping clinicians detect and monitor infections, autoimmune conditions, cancers, and other diseases.... Read more

Technology

view channel
Image: Conceptual design of the CORAL capsule for microbial sampling in the small intestine (H. Mohammed et al., Device (2025). DOI: 10.1016/j.device.2025.100904)

Coral-Inspired Capsule Samples Hidden Bacteria from Small Intestine

The gut microbiome has been linked to conditions ranging from immune disorders to mental health, yet conventional stool tests often fail to capture bacterial populations in the small intestine.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.